Gujarat Kidney And Super Speciality Limited (NSE:GKSL)
India · Delayed Price · Currency is INR 156.87
+0.50 (0.32%)
At close: Nov 12, 2026
NSE:GKSL Revenue
Gujarat Kidney And Super Speciality had revenue of 386.77M INR in the quarter ending September 30, 2026, with 199.15% growth. This brings the company's total for the last twelve months to 1.27B, up 155.99% year-over-year. In the fiscal year ending March 31, 2026, Gujarat Kidney And Super Speciality had annual revenue of 820.13M with 103.80% growth. That makes Gujarat Kidney And Super Speciality the 35,932nd largest company in the world by revenue and 3,008th in India.
Revenue (ttm)
1.27B
Revenue Growth
+155.99%
P/S Ratio
9.80
Revenue / Employee
6.51M
Employees
194
Market Cap
12.37B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 820.13M | 417.71M | 103.80% |
| Mar 31, 2025 | 402.42M | 354.68M | 742.89% |
| Mar 31, 2024 | 47.74M | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | 7.86M | -3.17M | -28.71% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Paras Healthcare | 18.05B |
| Indraprastha Medical Corporation | 15.55B |
| Shalby | 12.05B |
| Artemis Medicare Services | 11.50B |
| Nephrocare Health Services | 11.15B |
| Jeena Sikho Lifecare | 8.51B |
| GPT Healthcare | 5.10B |
| Max India | 2.84B |